Cargando…

Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China

BACKGROUND: Clostridium difficile carriage has been considered as a potential source for the deadly infection, but its role in cancer patients is still unclear. We aimed to identify the clinical and immunological factors that are related to C. difficile carriage in Chinese cancer patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Wei-Jia, Jing, Da-Zhi, Luo, Yun, Fu, Cai-Yun, Zhao, Peng, Qian, Jiong, Tian, Bing-Ru, Chen, Xiao-Gang, Zheng, Yu-Long, Zheng, Yi, Deng, Jing, Zou, Wei-Hua, Feng, Xue-Ren, Liu, Fan-Long, Mou, Xiao-Zhou, Zheng, Shu-Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261591/
https://www.ncbi.nlm.nih.gov/pubmed/25267108
http://dx.doi.org/10.1186/1471-2334-14-523
_version_ 1782348300222988288
author Fang, Wei-Jia
Jing, Da-Zhi
Luo, Yun
Fu, Cai-Yun
Zhao, Peng
Qian, Jiong
Tian, Bing-Ru
Chen, Xiao-Gang
Zheng, Yu-Long
Zheng, Yi
Deng, Jing
Zou, Wei-Hua
Feng, Xue-Ren
Liu, Fan-Long
Mou, Xiao-Zhou
Zheng, Shu-Sen
author_facet Fang, Wei-Jia
Jing, Da-Zhi
Luo, Yun
Fu, Cai-Yun
Zhao, Peng
Qian, Jiong
Tian, Bing-Ru
Chen, Xiao-Gang
Zheng, Yu-Long
Zheng, Yi
Deng, Jing
Zou, Wei-Hua
Feng, Xue-Ren
Liu, Fan-Long
Mou, Xiao-Zhou
Zheng, Shu-Sen
author_sort Fang, Wei-Jia
collection PubMed
description BACKGROUND: Clostridium difficile carriage has been considered as a potential source for the deadly infection, but its role in cancer patients is still unclear. We aimed to identify the clinical and immunological factors that are related to C. difficile carriage in Chinese cancer patients. METHODS: A total of 400 stool samples were collected from cancer patients who received chemotherapy in three hospitals of eastern China. Bacterial genomic DNA was extracted and two toxin genes (tcdA and tcdB) were detected. PCR ribotyping was performed using capillary gel electrophoresis. Concentrations of prostaglandin E2 (PGE2), transforming growth factor beta (TGF-β) and interleukin-10 (IL-10) were measured using enzyme-linked immunosorbent assay (ELISA) kits. RESULTS: Eighty-two (20.5%) samples were confirmed to be C. difficile-positive and positive for tpi, tcdA, and tcdB genes. The C. difficile-positive rates in patients with diarrhea and no diarrhea were 35% and 19.7%, respectively (p = 0.09). Patients who were younger than 50 years old and were hospitalized for at least 10 days had a C. difficile-positive rate as high as 35%. In contrast, patients who were older than 50 years old and were hospitalized for less than 10 days had a C. difficile-positive rate of only 12.7% (p = 0.0009). No association was found between C. difficile carriage and chemotherapy regimen, antibiotic drug use, or immunosuppressive mediators, such as prostaglandin E2 (PGE2), transforming growth factor beta (TGF-β), or interleukin-10 (IL-10). Twelve ribotypes of C. difficile were identified, but none of them belonged to ribotype 027. CONCLUSIONS: We conclude that younger patients and those with longer hospitalization stays may be more prone to C. difficile carriage. Studies of larger populations are warranted to clarify the exact role of C. difficile carriage in hospitalized cancer patients in China. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2334-14-523) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4261591
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42615912014-12-10 Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China Fang, Wei-Jia Jing, Da-Zhi Luo, Yun Fu, Cai-Yun Zhao, Peng Qian, Jiong Tian, Bing-Ru Chen, Xiao-Gang Zheng, Yu-Long Zheng, Yi Deng, Jing Zou, Wei-Hua Feng, Xue-Ren Liu, Fan-Long Mou, Xiao-Zhou Zheng, Shu-Sen BMC Infect Dis Research Article BACKGROUND: Clostridium difficile carriage has been considered as a potential source for the deadly infection, but its role in cancer patients is still unclear. We aimed to identify the clinical and immunological factors that are related to C. difficile carriage in Chinese cancer patients. METHODS: A total of 400 stool samples were collected from cancer patients who received chemotherapy in three hospitals of eastern China. Bacterial genomic DNA was extracted and two toxin genes (tcdA and tcdB) were detected. PCR ribotyping was performed using capillary gel electrophoresis. Concentrations of prostaglandin E2 (PGE2), transforming growth factor beta (TGF-β) and interleukin-10 (IL-10) were measured using enzyme-linked immunosorbent assay (ELISA) kits. RESULTS: Eighty-two (20.5%) samples were confirmed to be C. difficile-positive and positive for tpi, tcdA, and tcdB genes. The C. difficile-positive rates in patients with diarrhea and no diarrhea were 35% and 19.7%, respectively (p = 0.09). Patients who were younger than 50 years old and were hospitalized for at least 10 days had a C. difficile-positive rate as high as 35%. In contrast, patients who were older than 50 years old and were hospitalized for less than 10 days had a C. difficile-positive rate of only 12.7% (p = 0.0009). No association was found between C. difficile carriage and chemotherapy regimen, antibiotic drug use, or immunosuppressive mediators, such as prostaglandin E2 (PGE2), transforming growth factor beta (TGF-β), or interleukin-10 (IL-10). Twelve ribotypes of C. difficile were identified, but none of them belonged to ribotype 027. CONCLUSIONS: We conclude that younger patients and those with longer hospitalization stays may be more prone to C. difficile carriage. Studies of larger populations are warranted to clarify the exact role of C. difficile carriage in hospitalized cancer patients in China. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2334-14-523) contains supplementary material, which is available to authorized users. BioMed Central 2014-09-29 /pmc/articles/PMC4261591/ /pubmed/25267108 http://dx.doi.org/10.1186/1471-2334-14-523 Text en © Fang et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Fang, Wei-Jia
Jing, Da-Zhi
Luo, Yun
Fu, Cai-Yun
Zhao, Peng
Qian, Jiong
Tian, Bing-Ru
Chen, Xiao-Gang
Zheng, Yu-Long
Zheng, Yi
Deng, Jing
Zou, Wei-Hua
Feng, Xue-Ren
Liu, Fan-Long
Mou, Xiao-Zhou
Zheng, Shu-Sen
Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China
title Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China
title_full Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China
title_fullStr Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China
title_full_unstemmed Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China
title_short Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China
title_sort clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261591/
https://www.ncbi.nlm.nih.gov/pubmed/25267108
http://dx.doi.org/10.1186/1471-2334-14-523
work_keys_str_mv AT fangweijia clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT jingdazhi clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT luoyun clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT fucaiyun clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT zhaopeng clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT qianjiong clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT tianbingru clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT chenxiaogang clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT zhengyulong clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT zhengyi clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT dengjing clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT zouweihua clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT fengxueren clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT liufanlong clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT mouxiaozhou clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina
AT zhengshusen clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina